BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorzalka BB, Hill MN, Sun JC. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes. Eur J Pharmacol 2005;516:28-33. [PMID: 15913602 DOI: 10.1016/j.ejphar.2005.04.019] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Franklin JM, Carrasco GA. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. Synapse 2013;67:145-59. [PMID: 23151877 DOI: 10.1002/syn.21626] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
2 Ligresti A, De Petrocellis L, Di Marzo V. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology. Physiological Reviews 2016;96:1593-659. [DOI: 10.1152/physrev.00002.2016] [Cited by in Crossref: 184] [Cited by in F6Publishing: 175] [Article Influence: 30.7] [Reference Citation Analysis]
3 Parrish JC, Nichols DE. Serotonin 5-HT 2A receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. J Neurochem 2006;99:1164-75. [DOI: 10.1111/j.1471-4159.2006.04173.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
4 Connelly WM, Baggott MJ. Role of endocannabinoids in 5-HT2 receptor-mediated effects. J Neurophysiol 2009;101:5-7. [PMID: 19004992 DOI: 10.1152/jn.91054.2008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
5 Franke RT, Tarland E, Fink H, Pertz HH, Brosda J. 2-Bromoterguride-a potential atypical antipsychotic drug without metabolic effects in rats. Psychopharmacology (Berl) 2016;233:3041-50. [PMID: 27317020 DOI: 10.1007/s00213-016-4356-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Allan AM, Liang X, Luo Y, Pak C, Li X, Szulwach KE, Chen D, Jin P, Zhao X. The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum Mol Genet 2008;17:2047-57. [PMID: 18385101 DOI: 10.1093/hmg/ddn102] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
7 Hill MN, Froese LM, Morrish AC, Sun JC, Floresco SB. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists. Psychopharmacology (Berl) 2006;187:245-59. [PMID: 16752140 DOI: 10.1007/s00213-006-0421-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
8 Halberstadt AL, Geyer MA. Effect of Hallucinogens on Unconditioned Behavior. Curr Top Behav Neurosci 2018;36:159-99. [PMID: 28224459 DOI: 10.1007/7854_2016_466] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
9 Austgen JR, Kline DD. Endocannabinoids blunt the augmentation of synaptic transmission by serotonin 2A receptors in the nucleus tractus solitarii (nTS). Brain Res 2013;1537:27-36. [PMID: 24041777 DOI: 10.1016/j.brainres.2013.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
10 McLaughlin RJ, Hill MN, Gorzalka BB. Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. Eur J Pharmacol 2009;624:71-6. [PMID: 19818759 DOI: 10.1016/j.ejphar.2009.09.055] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
11 Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen. Psychopharmacology (Berl) 2019;236:821-30. [PMID: 30448990 DOI: 10.1007/s00213-018-5118-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
12 Marques AM, Macena MV, Cardoso AR, Hammes CSO, Pinheiro FML, Castro NG, Neves GA. Effects of combined 5-HT2A and cannabinoid receptor modulation on a schizophrenia-related prepulse inhibition deficit in mice. Psychopharmacology (Berl) 2020;237:1643-55. [PMID: 32095916 DOI: 10.1007/s00213-020-05485-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ruggieri V, Vitale G, Pini LA, Sandrini M. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol 2008;377:219-29. [PMID: 18404260 DOI: 10.1007/s00210-008-0284-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
14 Najar F, Nasehi M, Haeri-rohani S, Zarrindast M. The involvement of medial septum 5-HT 1 and 5-HT 2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2. J Psychopharmacol 2015;29:1200-8. [DOI: 10.1177/0269881115609021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
15 Riebe CJ, Lee TT, Hill MN, Gorzalka BB. Precipitated withdrawal counters the adverse effects of subchronic cannabinoid administration on male rat sexual behavior. Neurosci Lett 2010;472:171-4. [PMID: 20138966 DOI: 10.1016/j.neulet.2010.01.079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
16 Mato S, Aso E, Castro E, Martín M, Valverde O, Maldonado R, Pazos A. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. J Neurochem 2007;103:2111-20. [PMID: 17944876 DOI: 10.1111/j.1471-4159.2007.04961.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
17 Viñals X, Moreno E, Lanfumey L, Cordomí A, Pastor A, de La Torre R, Gasperini P, Navarro G, Howell LA, Pardo L, Lluís C, Canela EI, McCormick PJ, Maldonado R, Robledo P. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS Biol 2015;13:e1002194. [PMID: 26158621 DOI: 10.1371/journal.pbio.1002194] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 14.0] [Reference Citation Analysis]
18 Egashira N, Shirakawa A, Okuno R, Mishima K, Iwasaki K, Oishi R, Fujiwara M. Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice. Pharmacol Biochem Behav 2011;99:52-8. [PMID: 21504759 DOI: 10.1016/j.pbb.2011.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
19 Jahanshahi A, Le Maitre E, Temel Y, Lanfumey L, Hamon M, Lesch K, Tordera RM, Del Río J, Aso E, Maldonado R, Hökfelt T, Steinbusch HW. Altered expression of neuronal tryptophan hydroxylase-2 mRNA in the dorsal and median raphe nuclei of three genetically modified mouse models relevant to depression and anxiety. Journal of Chemical Neuroanatomy 2011;41:227-33. [DOI: 10.1016/j.jchemneu.2011.05.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
20 Mitazaki S, Nakagawasai O, Onogi H, Watanabe K, Takahashi K, Tan-no K, Quirion R, Srivastava LK, Tadano T. Role of prefrontal cortical 5-HT2A receptors and serotonin transporter in the behavioral deficits in post-pubertal rats following neonatal lesion of the ventral hippocampus. Behavioural Brain Research 2020;377:112226. [DOI: 10.1016/j.bbr.2019.112226] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Mannucci C, Navarra M, Pieratti A, Russo GA, Caputi AP, Calapai G. Interactions between endocannabinoid and serotonergic systems in mood disorders caused by nicotine withdrawal. Nicotine Tob Res 2011;13:239-47. [PMID: 21324836 DOI: 10.1093/ntr/ntq242] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
22 Halberstadt AL. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res. 2015;277:99-120. [PMID: 25036425 DOI: 10.1016/j.bbr.2014.07.016] [Cited by in Crossref: 135] [Cited by in F6Publishing: 114] [Article Influence: 16.9] [Reference Citation Analysis]
23 Buchborn T, Schröder H, Dieterich DC, Grecksch G, Höllt V. Tolerance to LSD and DOB induced shaking behaviour: Differential adaptations of frontocortical 5-HT2A and glutamate receptor binding sites. Behavioural Brain Research 2015;281:62-8. [DOI: 10.1016/j.bbr.2014.12.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]